RoundUp Litigation Update August 2022

Oxbryta was marketed as a revolutionary drug to help people suffering from sickle cell disease manage their most painful symptoms. Oxbryta was manufactured by Global Blood Therapeutics (which was later bought by Pfizer) and approved by the FDA in 2019 for children and adults 12 years old and older. It was approved for children four years old and up in 2021. Alarming results from post-launch trials showed that Oxbryta may increase the symptoms of sickle cell disease instead of decreasing them.

In recent years, the Church of Jesus Christ of Latter-day Saints (LDS), commonly known as the Mormon Church, has faced increasing legal scrutiny due to allegations of widespread abuse and institutional cover-ups. have come forward with claims of sexual, emotional, and physical abuse, many of which involve church leaders or institutions. These lawsuits have begun to take the form of mass tort claims, as multiple plaintiffs allege a systemic pattern of negligence and concealment within the organization.

OnlyFans has become a booming platform for influencers and content creators, allowing them to monetize their work directly through subscriptions. However, with the rise of digital content creation comes the inevitable challenge of copyright infringement. Many OnlyFans creators find their exclusive content stolen and redistributed on unaffiliated websites without their permission. If you’re an OnlyFans influencer facing this issue, you may have legal recourse to protect your rights.

Maryland recently made a landmark change to its legal landscape by eliminating the civil statute of limitations for child sexual abuse cases under the **Child Victims Act of 2023**. This law, upheld by the Maryland Supreme Court in February 2025, allows survivors to file lawsuits regardless of how much time has passed since the abuse occurred.

Florida is one of 12 “no-fault” insurance states, requiring drivers to carry Personal Injury Protection (PIP) insurance on vehicles operated in the state. PIP insurance allows injured drivers to receive compensation for damages and medical expenses by utilizing their insurance coverage.

Per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” have been a growing concern due to their persistence in the environment and potential health risks. Recent developments have highlighted new contamination sites and legal actions aimed at addressing these issues across the United States.

Suboxone, a medication that combines buprenorphine and naloxone, has been instrumental in helping individuals recover from opioid addiction. However, recent concerns over its film formulation have highlighted serious health risks, particularly regarding dental decay and tooth loss.

Mounjaro is an injectable drug approved by the FDA to treat type 2 diabetes. Although approved for managing diabetes, studies indicate that Mounjaro’s active ingredient, tirzepatide, may be more effective than Wegovy or Ozempic for weight loss. This has led to a rise in patients using Mounjaro off-label for weight management.

Nursing home abuse involves the mistreatment, neglect, or exploitation of residents in long-term care facilities. This includes skilled nursing homes, assisted living facilities, and other institutions responsible for the care of elderly or vulnerable adults. Under both federal and state laws, these facilities are required to provide residents with a safe, dignified, and compassionate environment.

Oxbryta is a prescription medication developed to help people with sickle cell disease (SCD). It works by improving the oxygen-carrying ability of red blood cells and reducing the complications that come with SCD, like pain crises and organ damage. While it’s been seen as a breakthrough for managing this condition, a recent recall has raised serious concerns about its safety.